BriaCell Therapeutics Corp.
BCTX · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $14 | $17 | $7 |
| Short-Term Investments | $7 | $10 | $0 | $0 |
| Receivables | $1 | $1 | $3 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $2 | $0 | $0 |
| Total Curr. Assets | $11 | $27 | $20 | $11 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $2 | $2 |
| Total NC Assets | $2 | $2 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13 | $30 | $23 | $14 |
| Liabilities | – | – | – | – |
| Payables | $2 | $5 | $5 | $7 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $1 | $0 |
| Total Curr. Liab. | $3 | $5 | $6 | $8 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1 | $1 |
| Total NC Liab. | $0 | $0 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4 | $6 | $7 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $102 | $140 | $130 | $126 |
| Retained Earnings | -$120 | -$154 | -$143 | -$144 |
| AOCI | -$0 | $38 | -$0 | -$0 |
| Other Equity | $28 | $0 | $31 | $23 |
| Total Equity | $10 | $25 | $17 | $5 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$1 | -$1 | -$1 |
| Total Liab. & Tot. Equity | $13 | $30 | $23 | $14 |
| Net Debt | -$3 | -$14 | -$17 | -$7 |